Robert E. Landry, EVP Finance CFO at REGENERON PHARMACEUTICALS, INC. (REGN), sold 4,952 shares at $794.61 ($3.8M) on 2023-02-06, disclosed to the SEC on 2023-02-07.
Open-market sale of $3.8M REGN by EVP Finance CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $764.50 | 739 | $565K | 14.7% |
| 2 | $764.50 | 739 | $565K | 14.7% |
| 3 | $774.29 | 2,248 | $1.7M | 45.4% |
| 4 | $783.05 | 51 | $40K | 1.0% |
| 5 | $784.27 | 113 | $89K | 2.3% |
| 6 | $784.27 | 113 |
| $89K |
| 2.3% |
| 7 | $785.88 | 78 | $61K | 1.6% |
| 8 | $785.88 | 78 | $61K | 1.6% |
| 9 | $786.45 | 85 | $67K | 1.7% |
| 10 | $786.45 | 85 | $67K | 1.7% |
| 11 | $787.47 | 58 | $46K | 1.2% |
| 12 | $788.62 | 99 | $78K | 2.0% |
| 13 | $788.62 | 99 | $78K | 2.0% |
| 14 | $789.05 | 49 | $39K | 1.0% |
| 15 | $790.41 | 10 | $8K | 0.2% |
| 16 | $791.00 | 3 | $2K | 0.1% |
| 17 | $793.33 | 2 | $2K | 0.0% |
| 18 | $794.61 | 99 | $79K | 2.1% |
| 19 | $794.61 | 99 | $79K | 2.1% |
| 20 | $795.41 | 59 | $47K | 1.2% |
| 21 | $796.43 | 18 | $14K | 0.4% |
| 22 | $797.43 | 28 | $22K | 0.6% |
| Total | $774.90 avg | 4,952 | $3.8M | 100% |
| Filing → |
| REGN | SELL | 2023-08-25 | $188K | — | Filing → |
| REGN | SELL | 2023-03-29 | $1.8M | — | Filing → |
| REGN | SELL | 2022-12-02 | $462K | — | Filing → |